Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2021-04-28

FDA Approved: ETODOLAC — Supplemental Application (Zydus Pharmaceuticals USA Inc.)

View source ↗

Summary

FDA approved a supplemental application for Etodolac submitted by Zydus Pharmaceuticals USA Inc.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Etodolac (Etodolac)

Snippet

SUPPL AP for ETODOLAC (ETODOLAC)